Phase 2 Trial of Chidamide-Lenalidomide-Dexamethasone(CRD) Regimen in R/R MM

NCT03605056 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: chidamide
DRUG: lenalidomide
DRUG: dexamethasone

Sponsor

Peng Liu

Collaborators

[object Object]